KR
KRMD.US KORU Medical Systems, Inc.
- Market cap
- USD 160M
- P/E
- -
- P/B
- 8.26x
- ROE
- 0.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is KRMD.US undervalued?
Graham numberThe Graham number of KORU Medical Systems, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
KORU Medical Systems, Inc. fundamental analysis
No fundamental analysis for KORU Medical Systems, Inc. yet.
KORU Medical Systems, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About KORU Medical Systems, Inc.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal h…
Full company profileKORU Medical Systems, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
KORU Medical Systems, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 12.3M | 16.0M | 17.4M | 23.2M | 24.2M | 23.5M | 27.9M | 28.5M | 33.6M | 41.1M | 47.2M |
| Gross Profit | 7.57M | 9.46M | 10.8M | 14.9M | 14.9M | 13.8M | 15.4M | 16.7M | 21.3M | 25.6M | 29.9M |
| Operating Income | -736K | 1.48M | 1.16M | 586K | -1.25M | -7.03M | -10.8M | -10.3M | -6.45M | -2.97M | -67.8K |
| EBITDA | -474K | 1.88M | 2.37M | 4.34M | 1.61M | -5.90M | -10.1M | -8.90M | -5.18M | -1.81M | 406K |
| Net Income | -535K | 1.09M | 911K | 564K | -1.21M | -4.56M | -8.66M | -13.7M | -6.07M | -2.64M | -449K |
| EPS | -0.01 | 0.03 | 0.02 | 0.01 | -0.03 | -0.10 | -0.19 | -0.30 | -0.13 | -0.06 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 8.17M | 9.28M | 10.5M | 13.9M | 39.9M | 41.3M | 42.3M | 28.5M | 27.2M | 28.2M | 28.8T |
| Total Liabilities | 1.49M | 1.61M | 1.58M | 2.65M | 3.76M | 4.79M | 11.0M | 8.11M | 10.4M | 11.2M | 9.39T |
| Shareholders' Equity | 6.68M | 7.67M | 8.96M | 11.2M | 36.2M | 36.5M | 31.3M | 20.4M | 16.8M | 17.0M | 19.4T |
| Cash & Short-term Investments | 3.58M | 4.24M | 3.74M | 5.87M | 27.3M | 25.3M | 17.4M | 11.5M | 9.58M | 8.87M | 7.36T |
| Total Debt | - | - | - | 382K | 239K | 604K | 4.93M | 4.45M | 3.99M | 3.50M | 3.17T |
| Cash Flow | |||||||||||
| Operating Cash Flow | -332K | 900K | 1.48M | 321K | -743K | -4.32M | -5.40M | -4.89M | -320K | 462K | -869K |
| Capital Expenditure | 415K | 218K | 481K | 426K | 1.06M | 375K | 2.80M | 815K | 1.30M | 933K | 1.25M |
| Free Cash Flow | -747K | 682K | 998K | -105K | -1.80M | -4.69M | -8.21M | -5.71M | -1.62M | -470K | -2.12M |
| Ratios | |||||||||||
| ROE | -8.0% | 14.2% | 10.2% | 5.0% | -3.4% | -12.5% | -27.6% | -67.5% | -36.1% | -15.5% | 0.0% |
| ROA | -6.5% | 11.7% | 8.6% | 4.1% | -3.0% | -11.0% | -20.5% | -48.3% | -22.3% | -9.4% | 0.0% |
| Net Profit Margin | -4.4% | 6.8% | 5.2% | 2.4% | -5.0% | -19.4% | -31.0% | -48.2% | -18.0% | -6.4% | -1.0% |
| Debt to Equity | - | - | - | 0.03x | 0.01x | 0.02x | 0.16x | 0.22x | 0.24x | 0.21x | 0.16x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
KORU Medical Systems, Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 185K | 0.00 | 32.7% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns KORU Medical Systems, Inc.
- Insiders 8.77%
- Institutions 58.59%
- Public & others 32.64%
- Shares outstanding 43.4M
- Free float 31.6M
Top funds holding KRMD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.25M | 2.72% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.12M | 2.42% | 0.00% | Oct 2026 |
| Fidelity Small Cap Index | 488K | 1.06% | 0.00% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 428K | 0.93% | -0.38% | Oct 2026 |
| Vanguard Russell 2000 ETF | 252K | 0.55% | -2.33% | Sep 2026 |
| Fidelity Extended Market Index | 181K | 0.39% | -23.29% | Sep 2026 |
| iShares Micro-Cap ETF | 131K | 0.28% | 0.00% | Oct 2026 |
| Schwab Small Cap Index | 102K | 0.22% | -10.13% | Sep 2026 |
| Fidelity Total Market Index | 83.7K | 0.18% | -0.05% | Sep 2026 |
| iShares Russell 2000 Small-Cap Idx Instl | 73.6K | 0.16% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 71.0K | 0.15% | 0.00% | Sep 2026 |
| Goldman Sachs ActiveBeta® US SmCp Eq ETF | 60.5K | 0.13% | 0.00% | Oct 2026 |
| Acuitas US Microcap Institutional | 56.1K | 0.12% | -1.38% | Jun 2026 |
| Nuveen Small Cap Blend Idx R6 | 55.3K | 0.12% | 0.00% | Sep 2026 |
| Bridgeway Ultra-Small Company | 51.8K | 0.11% | -31.21% | Jun 2026 |
| Vanguard Russell 2000 Growth ETF | 49.9K | 0.11% | -0.01% | Sep 2026 |
| Fidelity Small Cap Growth Index | 45.3K | 0.10% | +6.46% | Aug 2026 |
| Bridge Builder Small Cap Fund | 43.5K | 0.09% | 0.00% | Oct 2026 |
| EQ/2000 Managed Volatility IB | 43.0K | 0.09% | 0.00% | Sep 2026 |
Top institutions holding KRMD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| First Light Asset Management, LLC | 3.39M | 7.34% | -10.10% | Jun 2026 |
| Topline Capital Management LLC | 3.37M | 7.31% | -4.01% | Jun 2026 |
| BlackRock Inc | 2.63M | 5.69% | +10.82% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.82M | 3.94% | +7.82% | Jun 2026 |
| Geode Capital Management, LLC | 1.13M | 2.44% | +7.31% | Jun 2026 |
| Meros Investment Management, LP | 760K | 1.65% | -0.10% | Jun 2026 |
| Simcoe Capital LLC | 713K | 1.55% | -13.78% | Sep 2026 |
| Lionhunter Capital Management, LLC | 693K | 1.50% | 0.00% | Jun 2026 |
| State Street Corp | 647K | 1.40% | -0.41% | Jun 2026 |
| Archon Capital Management LLC | 643K | 1.39% | 0.00% | Jun 2026 |
| HRT FINANCIAL LLC | 353K | 0.76% | 0.00% | Jun 2026 |
| Northern Trust Corp | 347K | 0.75% | +7.73% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 326K | 0.71% | +6.41% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 323K | 0.70% | -12.48% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 310K | 0.67% | +21.29% | Jun 2026 |
| White Pine Capital LLC | 284K | 0.62% | -29.59% | Jun 2026 |
| Renaissance Technologies Corp | 236K | 0.51% | +43.00% | Sep 2026 |
| Qube Research & Technologies | 200K | 0.43% | +11.69% | Jun 2026 |
| Albion Financial Group (Utah) | 186K | 0.40% | -13.86% | Jun 2026 |
| Connor Clark & Lunn Inv Mgmt Ltd | 153K | 0.33% | +8.67% | Jun 2026 |
KORU Medical Systems, Inc. company profile
- Company name
- KORU Medical Systems, Inc.
- Ticker
- KRMD.US
- Exchange
- USA Stocks
- Listed since
- Mar 20, 1996
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 73
- Fiscal year end
- December
- Address
- 100 Corporate Drive, Mahwah, NJ, United States, 07430
- Phone
- 845 469 2042
- Website
- korumedical.com
About KORU Medical Systems, Inc.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
KORU Medical Systems, Inc. management
4- Mr. Adam KalbermattenPresident & CEO · born 1984
- Mr. Thomas AdamsCFO, Secretary & Treasurer · born 1973
- Mr. Christopher PazdanChief Operating Officer · born 1983
- Mr. Eric SchillerChief Technology Officer · born 1974